Advertisement
UK markets open in 6 hours 32 minutes

  • NIKKEI 225

    37,737.19
    -224.61 (-0.59%)
     

  • HANG SENG

    16,251.84
    +2.87 (+0.02%)
     

  • CRUDE OIL

    82.77
    +0.08 (+0.10%)
     

  • GOLD FUTURES

    2,382.60
    -5.80 (-0.24%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • Bitcoin GBP

    49,060.82
    -2,123.27 (-4.15%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,683.37
    -181.88 (-1.15%)
     

  • UK FTSE All Share

    4,273.02
    +12.61 (+0.30%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

Sarissa Capital Management LP Buys Alkermes PLC, Vor Biopharma Inc, Sells BioCryst ...

GuruFocus.com
·2-min read

- By insider

Greenwich, CT, based Investment company Sarissa Capital Management LP (Current Portfolio) buys Alkermes PLC, Vor Biopharma Inc, sells BioCryst Pharmaceuticals Inc during the 3-months ended 2021Q2, according to the most recent filings of the investment company, Sarissa Capital Management LP. As of 2021Q2, Sarissa Capital Management LP owns 14 stocks with a total value of $1.3 billion. These are the details of the buys and sells.

  • New Purchases: VOR,

  • Added Positions: ALKS,

  • Reduced Positions: BCRX,


For the details of Sarissa Capital Management LP's stock buys and sells,
go to https://www.gurufocus.com/guru/sarissa+capital+management+lp/current-portfolio/portfolio

ADVERTISEMENT

These are the top 5 holdings of Sarissa Capital Management LP

  1. Alkermes PLC (ALKS) - 11,870,000 shares, 23.14% of the total portfolio. Shares added by 49.31%

  2. Biogen Inc (BIIB) - 643,000 shares, 17.70% of the total portfolio.

  3. Ironwood Pharmaceuticals Inc (IRWD) - 16,390,000 shares, 16.77% of the total portfolio.

  4. Gilead Sciences Inc (GILD) - 2,697,400 shares, 14.77% of the total portfolio.

  5. (ALXN) - 650,440 shares, 9.50% of the total portfolio.

New Purchase: Vor Biopharma Inc (VOR)

Sarissa Capital Management LP initiated holding in Vor Biopharma Inc. The purchase prices were between $18.65 and $43.1, with an estimated average price of $25.11. The stock is now traded at around $13.390000. The impact to a portfolio due to this purchase was 1.05%. The holding were 707,010 shares as of 2021-06-30.

Added: Alkermes PLC (ALKS)

Sarissa Capital Management LP added to a holding in Alkermes PLC by 49.31%. The purchase prices were between $18.68 and $25.15, with an estimated average price of $22.15. The stock is now traded at around $30.095000. The impact to a portfolio due to this purchase was 7.64%. The holding were 11,870,000 shares as of 2021-06-30.



Here is the complete portfolio of Sarissa Capital Management LP. Also check out:

1. Sarissa Capital Management LP's Undervalued Stocks

2. Sarissa Capital Management LP's Top Growth Companies, and

3. Sarissa Capital Management LP's High Yield stocks

4. Stocks that Sarissa Capital Management LP keeps buyingThis article first appeared on GuruFocus.